Adial Pharmaceuticals (ADIL) Institutional Ownership $0.71 -0.01 (-2.02%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.70 -0.01 (-1.24%) As of 05/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Adial Pharmaceuticals (NASDAQ:ADIL)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$86.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$19.27K Get ADIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Adial Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADIL Institutional Buying and Selling by Quarter Adial Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC54,508$55K0.0%+63.8%0.850% 2/13/2025 Renaissance Technologies LLC47,613$48K0.0%N/A0.743% 2/12/2025 Geode Capital Management LLC61,847$62K0.0%+36.0%0.965% 8/9/2024 Renaissance Technologies LLC34,346$39K0.0%-32.8%0.811% 5/20/2024 Virtu Financial LLC20,469$27K0.0%N/A0.484% 2/13/2024 Armistice Capital LLC159,000$296K0.0%N/A9.578% 11/9/2023 Manchester Capital Management LLC48,097$134K0.0%-96.0%3.942% 5/9/2023 Manchester Capital Management LLC1,202,452$421K0.1%N/A4.216% 11/7/2022 Virtu Financial LLC77,694$27K0.0%+142.7%0.301% 8/2/2022 Thompson Davis & CO. Inc.21,000$28K0.0%N/A0.088% Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/22/2022 Truist Financial Corp33,862$45K0.0%N/A0.142% 7/13/2022 Private Advisor Group LLC21,400$29K0.0%-37.3%0.090% 11/12/2021 Oppenheimer & Co. Inc.38,500$165K0.0%+37.5%0.190% 11/12/2021 NorthRock Partners LLC10,000$43K0.0%N/A0.049% 10/29/2021 Commonwealth Equity Services LLC36,461$156K0.0%+25.5%0.180% 9/17/2021 Virtu Financial LLC31,038$79K0.0%N/A0.153% 8/16/2021 State Street Corp48,954$125K0.0%N/A0.260% 8/13/2021 Northern Trust Corp21,873$56K0.0%N/A0.116% 8/13/2021 Geode Capital Management LLC88,246$225K0.0%+13.2%0.469% 8/13/2021 Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112% 8/11/2021 Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155% 8/3/2021 Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152% 7/17/2021Golden Green Inc.24,700$63K0.0%N/A0.134% 5/14/2021 Dimensional Fund Advisors LP31,410$76K0.0%+68.8%0.179% 5/13/2021 Barclays PLC15,850$38K0.0%N/A0.091% 5/12/2021 Rede Wealth LLC15,000$36K0.0%N/A0.086% 5/10/2021 Oppenheimer & Co. Inc.14,500$35K0.0%N/A0.083% 5/4/2021 Commonwealth Equity Services LLC22,050$53K0.0%+107.3%0.126% 3/8/2021 Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129% (Data available from 1/1/2016 forward) ADIL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADIL shares? During the previous two years, the following institutional investors and hedge funds held shares of Adial Pharmaceuticals shares: Armistice Capital LLC ($296K), Manchester Capital Management LLC ($134K), Geode Capital Management LLC ($62K), Citadel Advisors LLC ($55K), and Renaissance Technologies LLC ($48K), Virtu Financial LLC ($27K).Learn more on ADIL's institutional investors. What percentage of Adial Pharmaceuticals stock is owned by institutional investors? 16.41% of Adial Pharmaceuticals stock is owned by institutional investors. Learn more on ADIL's institutional investor holdings. Which institutional investors have been buying Adial Pharmaceuticals stock? The following institutional investors have purchased Adial Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($159K), Renaissance Technologies LLC ($47.61K), Citadel Advisors LLC ($21.24K), Virtu Financial LLC ($20.47K), and Geode Capital Management LLC ($16.38K). How much institutional buying is happening at Adial Pharmaceuticals? Institutional investors have bought a total of 264,701 shares in the last 24 months. This purchase volume represents approximately $409.05K in transactions. Which Adial Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.15M), and Renaissance Technologies LLC ($16.75K). How much institutional selling is happening at Adial Pharmaceuticals? Institutional investors have sold a total of 1,171,109 shares in the last 24 months. This volume of shares sold represents approximately $3.23M in transactions. Related Companies Synergy CHC Corp. (Uplisting) Major Shareholders Cingulate Major Shareholders Lipocine Major Shareholders Leap Therapeutics Major Shareholders Unity Biotechnology Major Shareholders Upexi Major Shareholders Moleculin Biotech Major Shareholders NeuroSense Therapeutics Major Shareholders IN8bio Major Shareholders Flora Growth Major Shareholders This page (NASDAQ:ADIL) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
